Arthur S. Przybyl

2015

In 2015, Arthur S. Przybyl earned a total compensation of $3M as President, Chief Executive Officer and Director at ANI Pharmaceuticals, a 68% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$343,200
Option Awards$998,400
Salary$568,331
Stock Awards$1,030,650
Other$10,000
Total$2,950,581

Przybyl received $1M in stock awards, accounting for 35% of the total pay in 2015.

Przybyl also received $343.2K in non-equity incentive plan, $998.4K in option awards, $568.3K in salary and $10K in other compensation.

Rankings

In 2015, Arthur S. Przybyl's compensation ranked 3,231st out of 13,638 executives tracked by ExecPay. In other words, Przybyl earned more than 76.3% of executives.

ClassificationRankingPercentile
All
3,231
out of 13,638
76th
Division
Manufacturing
1,169
out of 5,190
78th
Major group
Chemicals And Allied Products
424
out of 1,854
77th
Industry group
Drugs
335
out of 1,528
78th
Industry
Pharmaceutical Preparations
267
out of 1,182
77th
Source: SEC filing on April 6, 2017.

Przybyl's colleagues

We found three more compensation records of executives who worked with Arthur S. Przybyl at ANI Pharmaceuticals in 2015.

2015

Charlotte Arnold

ANI Pharmaceuticals

Chief Financial Officer

2015

Robert Schrepfer

ANI Pharmaceuticals

Senior Vice President, New Business Development and Specialty Sales

2015

James Marken

ANI Pharmaceuticals

Senior Vice President, Operations and Product Development

News

You may also like